Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001547522-14-000116)

Filing Details

Accession Number:: 0001547522-14-000116
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-26 13:18:15
Reporting Period:: 2014-11-25

Filing Date:: 2014-11-26
Accepted Time:: 2014-11-26 13:18:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
811641	Immucell Corp	ICCC	In Vitro & In Vivo Diagnostic Substances (2835)	010382980

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1043218	E Jonathan Rothschild	C/O Immucell Corporation 56 Evergreen Drive Portland ME 04103		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.10 Per Share	Acquisiton	2014-11-25	1,000	$4.79	514,436	No	4	P	Direct
Common Stock, Par Value $0.10 Per Share	Acquisiton	2014-11-25	500	$4.79	514,936	No	4	P	Direct
Common Stock, Par Value $0.10 Per Share	Acquisiton	2014-11-26	300	$4.87	515,236	No	4	P	Direct
Common Stock, Par Value $0.10 Per Share	Acquisiton	2014-11-26	300	$4.90	515,536	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

These shares were acquired by Arterio Inc., a corporation owned solely by Mr. Rothschild.
This figure includes 217,055 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild, and 39,555 shares held by the estate of Mr. Rothschild's parents. Mr. Rothschild is the executor of his parents' estate and is a one-third beneficiary of that estate. The distribution of the assets of that estate has not yet been resolved.